In addition, some studies have reported JAK2 mutation rates ranging from about 83 to 90% in patients with PV in Asia [27,28,29], and the results of this study are largely consistent with them; therefore, this difference may also be related to ethnicity and region. Here, JAK2 is linked to acquired polycythemia vera.